Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
25.6M
-
Shares change
-
-583K
-
Total reported value, excl. options
-
$288M
-
Value change
-
-$5.84M
-
Number of buys
-
46
-
Number of sells
-
-47
-
Price
-
$11.25
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2021
109 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2021.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.6M shares
of 37.4M outstanding shares and own 68.37% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (3.15M shares), Legion Partners Asset Management, LLC (2.93M shares), BlackRock Inc. (2.21M shares), DIMENSIONAL FUND ADVISORS LP (2.07M shares), Cove Street Capital, LLC (1.79M shares), VANGUARD GROUP INC (1.4M shares), INVESTMENT COUNSELORS OF MARYLAND LLC (1.24M shares), HEARTLAND ADVISORS INC (1.23M shares), KENNEDY CAPITAL MANAGEMENT, INC. (885K shares), and Russell Investments Group, Ltd. (755K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.